Written by: Jose Guizar Real, MSc
Reviewed by: Yiming (Amy) Qin, PhD, RD
Something shifts in your 40s that is hard to put into words. Not a single dramatic change, but a gradual accumulation of things that feel slightly off. You are more tired than you used to be. Your mood feels less predictable. You do not feel as rested as before when sleeping. And sometimes you find yourself wondering if this is just what getting older feels like, or if something else is going on.
What Is Actually Happening in Your Body
Your body runs on hormones, and two of them, estrogen and progesterone, have been quietly regulating everything from your mood and sleep to your energy and metabolism since puberty. During perimenopause, which can begin anywhere from your late 30s to mid-40s and last up to ten years, the ovaries gradually start producing less of both.¹
-
Unpredictable Estrogen: Estrogen levels become erratic, rising higher than normal some months and dropping sharply in others.
-
Steady Progesterone Decline: Progesterone tends to decline earlier and more steadily.
How This Transition Affects Your Body
Estrogen and progesterone act as messengers across almost every system in your body, which is why their decline can be felt in so many different places at once. Here is where women most commonly notice it:
🧠 The Brain and Nervous System
Both estrogen and progesterone keep the nervous system calm, and when their levels become unpredictable, the effects show up quickly. Anxiety, fatigue, and mood swings are among the first things women notice.¹·⁸ Estrogen is a master regulator of brain function, and when its levels begin to shift during perimenopause, up to 80% of women experience changes in mood, sleep, or how clearly they can think.¹¹
[Explore the Brain and Nervous System series → ]
🌡️ Sleep and Thermoregulation
Hot flashes and night sweats are among the most recognized symptoms of this transition. They happen because estrogen influences the brain's thermoregulatory centers, including specialized neurons in the hypothalamus. When estrogen levels decline, the thermoneutral zone, the range of temperatures the body tolerates without triggering a heating or cooling response, narrows, making the body more likely to trigger heat-dissipation responses like flushing and sweating.⁴ More than 50% of women experience frequent vasomotor symptoms, and in about half of those women, these symptoms last more than 7 years.¹³
🍃 Metabolism and Weight
Many women notice their body responding differently to food and exercise even when nothing about their habits has changed. The way the body stores fat and manages blood sugar is tied more closely to estrogen than most people realize.⁵ Declining estrogen contributes to reduced energy expenditure and a shift in fat distribution from the hips and thighs toward the abdomen, along with changes in insulin sensitivity and cholesterol levels.¹⁴·¹⁵
[Explore the Metabolism and Weight series → ]
🦠 Gut Health and Digestion
Bloating and digestive changes that seem to appear without explanation are more common during this transition than most women realize. Declining estrogen appears to influence the gut microbiome, and the digestive system often feels it before anything else.⁶ Emerging research also suggests that menopause is associated with shifts in gut microbial diversity and changes in gut motility. This is a newer area of study and the exact mechanisms are still being investigated.¹⁶·¹⁷
[Explore the Gut Health series → ]
🦴 Bone and Cardiovascular Health
Two of the most significant effects of this transition happen quietly in the background. As estrogen declines, bones gradually lose density, making them more fragile over time.¹⁹ The heart and blood vessels are also affected, with shifts in cholesterol levels and blood pressure that tend to develop slowly and without obvious symptoms.¹⁵·¹⁹ Most women do not feel these changes right away, which is what makes this transition worth paying attention to early.
[Explore the Bone and Cardiovascular Health series → ]
✨ Skin, Hair and Cellular Aging
Skin that feels drier and hair that seems thinner are among the more visible signs of this transition. Collagen production slows as estrogen declines, with studies showing an average loss of about 2% of skin collagen per year in the first 15 to 18 years after menopause.⁷·¹⁸ Most women notice the difference in their skin and hair before they connect it to anything hormonal.
[Explore the Skin, Hair and Cellular Aging series → ]
You Are Not Imagining It
One of the most common things women say about this transition is that they felt like something was wrong with them before they understood what was happening. What you are feeling is real, and it makes complete biological sense.
-
Brinton RD, Yao J, Yin F, Mack WJ, Bhatt D. Perimenopause as a neurological transition state. Nat Rev Endocrinol. 2015;11(7):393-405. doi:10.1038/nrendo.2015.82
-
Harlow SD, Gass M, Hall JE, et al; for the STRAW + 10 Collaborative Group. Executive summary of the Stages of Reproductive Aging Workshop + 10: addressing the unfinished agenda of staging reproductive aging. J Clin Endocrinol Metab. 2012;97(4):1159-1168. doi:10.1210/jc.2011-3362
-
Wylenzek F, Bühling KJ, Laakmann E. A systematic review on the impact of nutrition and possible supplementation on the deficiency of vitamin complexes, iron, omega-3-fatty acids, and lycopene in relation to increased morbidity in women after menopause. Arch Gynecol Obstet. 2024. doi:10.1007/s00404-024-07555-6
-
Gombert-Labedens M, Vesterdorf K, Fuller A, Maloney SK, Baker FC. Effects of menopause on temperature regulation. Temperature. 2025;12(2):92-132. doi:10.1080/23328940.2025.2484499
-
Lizcano F, Guzmán G. Estrogen deficiency and the origin of obesity during menopause. Biomed Res Int. 2014;2014:757461. doi:10.1155/2014/757461
-
Liaquat M, Minihane AM, Vauzour D, Pontifex MG. The gut microbiota in menopause: is there a role for prebiotic and probiotic solutions? Ther Adv Endocrinol Metab. 2025. doi:10.1177/20533691251340491
-
Viscomi B, Muniz M, Sattler S. Managing menopausal skin changes: a narrative review of skin quality changes, their aesthetic impact, and the actual role of hormone replacement therapy in improvement. J Cosmet Dermatol. 2025;24:e70393. doi:10.1111/jocd.70393
-
Stefaniak M, Dmoch-Gajzlerska E, Jankowska K, Rogowski A, Kajdy A, Maksym RB. Progesterone and its metabolites play a beneficial role in affect regulation in the female brain. Pharmaceuticals. 2023;16(4):520. doi:10.3390/ph16040520
-
Barth C, Crestol A, de Lange AG, Galea LAM. Sex steroids and the female brain across the lifespan: insights into risk of depression and Alzheimer's disease. Lancet Diabetes Endocrinol. 2023;11(12):926-941. doi:10.1016/S2213-8587(23)00224-3
-
Hynd M. The brain in transition: perimenopause through a translational lens. Neurosci Biobehav Rev. 2026. doi:10.1016/j.neubiorev.2026.42190977
-
Aras SG, Grant AD, Konhilas JP. Clustering of > 145,000 symptom logs reveals distinct pre, peri, and menopausal phenotypes. Sci Rep. 2025;15(1):640. doi:10.1038/s41598-024-84208-3
-
Hamoda H, Moger S, Morris E, et al. Menopause practice standards. Clin Endocrinol. 2024. doi:10.1111/cen.14789
-
Crandall CJ, Mehta JM, Manson JE. Management of menopausal symptoms: a review. JAMA. 2023. doi:10.1001/jama.2022.24140
-
Kapoor E, Collazo-Clavell ML, Faubion SS. Weight gain in women at midlife: a concise review of the pathophysiology and strategies for management. Mayo Clin Proc. 2017;92(10):1552-1558. doi:10.1016/j.mayocp.2017.08.004
-
Nappi RE, Chedraui P, Lambrinoudaki I, Simoncini T. Menopause: a cardiometabolic transition. Lancet Diabetes Endocrinol. 2022;10(6):442-456. doi:10.1016/S2213-8587(22)00076-6
-
Ley D, Saha S. Menopause and gastrointestinal health and disease. Nat Rev Gastroenterol Hepatol. 2025. doi:10.1038/s41575-025-01040-6
-
Palacios S, Martin J, Hernandez I, Orozco R. Estradiol loss, the estrobolome, and midlife symptoms: what the gut microbiome adds to menopause care. Menopause. 2026. doi:10.1097/GME.0000000000002542
-
Verdier-Sévrain S, Bonté F, Gilchrest B. Biology of estrogens in skin: implications for skin aging. Exp Dermatol. 2006;15(2):83-94. doi:10.1111/j.1600-0625.2005.00377.x
-
El Khoudary SR, Aggarwal B, Beckie TM, et al. Menopause transition and cardiovascular disease risk: implications for timing of early prevention: a scientific statement from the American Heart Association. Circulation. 2020;142(25):e506-e532. doi:10.1161/CIR.0000000000000912



Dejar un comentario
Todos los comentarios se revisan antes de su publicación.
Este sitio está protegido por hCaptcha y se aplican la Política de privacidad de hCaptcha y los Términos del servicio.